B7-H3 Negatively Modulates CTL-Mediated Cancer ImmunityKimio Yonesaka, Kazuhiko Nakagawa, Ryoji Kato et al.|Clinical Cancer Research|2018Cited by 169
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung CancerKimio Yonesaka, Kazuhiko Nakagawa, Junko Tanizaki et al.|Clinical Cancer Research|2021Cited by 92